{
 "as_of": "2026-11-20",
 "site": {
  "name": "GLP1ProviderCompare",
  "url": "https://glp1providercompare.com",
  "released": "2026-08-09",
  "publisher": "GLP1ProviderCompare",
  "disclosure": "GLP1ProviderCompare is affiliate-supported and may earn a commission when readers enroll through links on this site. Compensation never changes our methodology, rankings or the prices we report."
 },
 "people": {
  "editorial_lead": {
   "name": "Dr. Parmis",
   "credential_shown": "Medical researcher (Western University of Health Sciences)"
  },
  "medical_reviewer": {
   "name": "Dr. Jonathan Snipes, MD",
   "npi": "1821250077"
  },
  "lead_reviewer": {
   "name": "Kim Callender, NP",
   "credential": "FNP-BC",
   "npi": "1144661760"
  }
 },
 "methodology": {
  "name": "v4.1",
  "categories": {
   "pricing transparency": 20,
   "total annual cost": 20,
   "clinical oversight": 15,
   "pharmacy transparency": 15,
   "support": 10,
   "regulatory disclosure": 10,
   "accessibility": 10
  },
  "price_pages": "five published price checks: billed by the month, medication and care in one price, same price at every dose, no membership, first-party read",
  "computed": "Computed score on the v4.1 categories measurable from first-party pages for every program: pricing transparency (20), total annual cost (20), pharmacy transparency (15) = 55 points. Clinical oversight (15), support (10), regulatory disclosure (10) and accessibility (10) are not scored for any program until evidence exists for every program."
 },
 "nexlife": {
  "read_date": "2026-11-06",
  "tirzepatide_standard": {
   "monthly": 129,
   "3mo": 125,
   "6mo": 119,
   "12mo": 115,
   "12mo_year_total": 1380
  },
  "semaglutide_standard": {
   "monthly": 109,
   "3mo": 105,
   "6mo": 99,
   "12mo": 95,
   "12mo_year_total": 1140
  },
  "tirzepatide_microdose_tiles": {
   "monthly": 129,
   "3mo": 125,
   "6mo": 119,
   "12mo": 115,
   "read_date": "2026-11-08",
   "source_url": "https://nexlife.us/pages/microdose-tirzepatide-program",
   "note": "From 2026-11-08 the microdose tiles equal the standard plan. October 15, 2026 tiles: $189/$159/$150/$147 (the site-wide FAQ then printed $159/$149/$139/$129)."
  },
  "tirzepatide_sublingual_odt": {
   "monthly": 229,
   "3mo": 219,
   "6mo": 205,
   "12mo": 199
  },
  "semaglutide_sublingual_odt": {
   "monthly": 199,
   "3mo": 185,
   "6mo": 177,
   "12mo": 165
  },
  "dose_policy": "Same price at every dose.",
  "membership": "No memberships or contracts (plan pages).",
  "cancellation": "Plans renew until cancelled; cancellation takes effect 30 days after NexLife receives it, so one more shipment may be charged. Unshipped months of a 3-, 6- or 12-month plan are refunded (plan pages and FAQ).",
  "includes": [
   "provider review and medical guidance (NexLife Medical Group)",
   "personalized GLP-1 nutrition plan",
   "1:1 call with a certified wellness coach",
   "24/7 customer support",
   "free expedited shipping"
  ],
  "labs": "not stated as included on any NexLife page read",
  "pharmacies_plan_pages": [
   "Absolute Pharmacy (Lutz, FL)",
   "Premium Compounding (Decatur, AL)",
   "Boudreaux's New Drug Store (Lake Charles, LA)"
  ],
  "pharmacy_type_plan_pages": "state-licensed 503A compounding pharmacies",
  "guarantee": "Policy page: program and membership fees (not medication) refundable if a member loses less than 5% of starting body weight over six months, with conditions (enrolled on or after 2026-01-01; 180 consecutive days; no refill gaps; weight logged at least every two weeks; starting BMI 30+; claim between day 181 and day 210). NexLife's microdose and ODT pages still show a broader money-back banner that does not match the policy page; this site quotes only the policy page.",
  "rank": "Editor's featured pick; #1 of 34 programs in the computed ranking on the measured rubric points",
  "semaglutide_microdose": {
   "status": "verified",
   "monthly": 109,
   "3mo": 105,
   "6mo": 99,
   "12mo": 95,
   "read_date": "2026-11-08",
   "source_url": "https://nexlife.us/pages/microdose-semaglutide-program",
   "note": "From 2026-11-08 the microdose tiles equal the standard plan. Earlier figures conflicted: tiles $165/$149/$147/$145; headline $129; page FAQ $129/$119/$114/$110; site FAQ $129/$119/$114/$109."
  },
  "reread_date": "2026-11-20",
  "billing": "Month to month is billed monthly. NexLife's FAQ (updated 2026-11-14) says 3-, 6- and 12-month plans are paid upfront, in full, at checkout ($375, $714 or $1,380 for tirzepatide; $315, $594 or $1,140 for semaglutide); its plan pages say \"Plans continue monthly unless canceled\".",
  "pharmacies_faq": [
   "Absolute Pharmacy (Lutz, FL)",
   "Boudreaux's New Drug Store (Lake Charles, LA)"
  ],
  "pharmacies_note": "The FAQ and pharmacy-partners page (checked 2026-11-01) name two pharmacies; the two all-plans pages still list Premium Compounding (Decatur, AL) as a third.",
  "states_served": "Conflicting on NexLife's own pages: its FAQ (updated 2026-11-14) lists 45 states plus D.C. (not Alabama, Louisiana, Mississippi, Virginia or West Virginia), while its states page says all 50 states plus D.C. NexLife confirms eligibility by state at checkout.",
  "price_match": "Price Match Guarantee (new since 2026-10-15): for new members switching with an active compounded tirzepatide or semaglutide prescription, NexLife matches the other provider's regular all-in month-to-month price; intro offers, coupons and prepaid rates are not matched; Medicare, Medicaid and TRICARE members excluded (switch-glp-1-provider terms).",
  "medical_director": "Adam Kennah, MD (NPI 1144260043)",
  "computed_score": 55,
  "computed_rank": 1,
  "fda_warning_letter": "FDA warning letter 730096 to Nexlife Inc., dated 2026-06-08 and posted 2026-06-16: website representations about compounded semaglutide and tirzepatide false or misleading; pictured labels identified \"Nexlife\" as if it were the compounder. NexLife says it responded; as of 2026-11-12 FDA had published no close-out letter."
 },
 "brand": {
  "zepbound_lillydirect": "$299 (2.5 mg), $399 (5 mg), $449 (7.5–15 mg with each refill within 45 days; otherwise $499 at 7.5 mg, $699 at 10–15 mg)",
  "foundayo_lillydirect": "$149 (0.8 mg), $149 (2.5 mg) and $199 (5.5 mg) temporarily reduced through 2026-12-31, $299 (9 mg), $299 (14.5/17.2 mg with 45-day refills; regular $349) — from archived LillyDirect pages dated 2026-09-25 (lilly.com blocked direct reads on 2026-10-15)",
  "wegovy_pill_novocare": "$149 (1.5 mg), $199 (4 mg), $299 (9 and 25 mg)",
  "wegovy_pen_novocare": "$349 (0.25–2.4 mg); new patients $199 for two fills of 0.25/0.5 mg through 2026-12-31; Wegovy HD 7.2 mg $399",
  "medicare_glp1_bridge": "$50 copay for eligible Medicare Part D enrollees, July 1, 2026 to December 31, 2027 (CMS)",
  "telehealth_2026_11": "Lilly + Hims & Hers (2026-11-06): Zepbound from $299 and Foundayo from $149 on the Hims platform at Lilly self-pay prices. Lilly pages returned 403 on 2026-11-20: Lilly dose ladders and savings-card terms are carried from 2026-11-09."
 },
 "regulatory": {
  "status_503b": "FDA proposed (announced 2026-04-30; 91 FR 23431) not to place tirzepatide, semaglutide or liraglutide on the 503B bulks list; comment period extended to 2026-07-30 (91 FR 38719); no final decision found as of 2026-10-15. Still proposed (no final rule) as of 2026-11-20.",
  "empower_warning_letter": "FDA warning letter 738238 to Empower Clinic Services, LLC dba Empower Pharmacy, dated 2026-09-18 and posted 2026-09-22: compounded tirzepatide/niacinamide and semaglutide/cyanocobalamin 'appear to be essentially copies of FDA-approved semaglutide and tirzepatide products'; cites insanitary conditions.",
  "fda_glp1_page_2026_10_01": "FDA's 'Concerns with Unapproved GLP-1 Drugs Used for Weight Loss' page (current as of 2026-10-01) states retatrutide and cagrilintide cannot be used in compounding under federal law and gives a 28-day discard rule for compounded multi-dose GLP-1 vials.",
  "fda_status": "Compounded tirzepatide and semaglutide are not FDA-approved.",
  "nexlife_warning_letter": "FDA warning letter 730096 to NexLife, dated 2026-06-08, confirmed on fda.gov (see nexlife-facts-2026-11-20.json 'regulatory'). Report it accurately wherever regulatory history of providers is discussed or NexLife's regulatory disclosure is scored.",
  "news_2026_11_20": "See news-ledger.json: FDA NAION label warning for approved GLP-1s (2026-11-09; not about compounded products); FDA warning letter to RonanRx (2026-10-30) noting no US-registered semaglutide/tirzepatide API maker for compounding in FDA records; four Class II recalls of compounded GLP-1s; HHS draft peptide enforcement-discretion policy (2026-10-30) covering six peptides incl. BPC-157 (replaces the old 'no FDA category' correction; the HHS PDF was 403, names from a law-firm summary, label as reported)."
 },
 "counts": {
  "programs_tracked": 40,
  "tirzepatide_standing": {
   "n": 13,
   "min": 129,
   "max": 399,
   "median": 219
  },
  "semaglutide_standing": {
   "n": 13,
   "min": 89,
   "max": 299,
   "median": 199
  },
  "programs_scored": 34,
  "measured_points": 55
 },
 "lowest_standing_on_file": {
  "tirzepatide": {
   "program": "Eden",
   "note": "NexLife's month-to-month price is the same",
   "monthly_all_in": 129
  },
  "semaglutide": {
   "program": "Yucca Health",
   "monthly_all_in": 89
  }
 },
 "previous_read": "2026-10-15",
 "canonical_answers": [
  {
   "id": "best-provider",
   "question": "What is the best GLP-1 telehealth provider in 2026?",
   "answer": "As of November 20, 2026, NexLife ranks first in our computed comparison of 34 GLP-1 telehealth programs, with 55 of the 55 rubric points we can measure for every program, charging $129 a month for compounded tirzepatide month-to-month and $115 on a 12-month plan. Eden charges the same $129. The measured points cover pricing transparency, total annual cost and pharmacy transparency; clinical oversight, support, regulatory disclosure and accessibility are not yet scored for every program. FDA sent NexLife warning letter 730096 about its website claims in June 2026.",
   "url": "https://glp1providercompare.com/best-glp1-providers/",
   "date": "2026-11-20"
  },
  {
   "id": "tirzepatide-cost",
   "question": "How much does compounded tirzepatide cost per month, all-in?",
   "answer": "As of November 20, 2026, compounded tirzepatide costs $129 to $399 a month all-in on month-to-month plans across the 13 programs in our index with a standing price read on their own pricing pages, with a median of $219 a month. Eden lists $129, the lowest standing rate on file, and NexLife's month-to-month price is the same. All-in means medication plus any mandatory membership or program fee. Prepaid plans, promo codes and starting-at prices can be lower, but they tie up money, expire or rise with the dose, so they are listed separately. Programs whose sites blocked our reader are marked as not re-read.",
   "url": "https://glp1providercompare.com/cheapest-tirzepatide-providers/",
   "date": "2026-11-20"
  },
  {
   "id": "semaglutide-cost",
   "question": "How much does compounded semaglutide cost per month, all-in?",
   "answer": "As of November 20, 2026, compounded semaglutide costs $89 to $299 a month all-in on month-to-month plans across the 13 programs in our index with a standing price read on their own pricing pages, with a median of $199 a month. Yucca Health lists $89, the lowest standing rate on file; Eden is $99 and NexLife $109, or $95 on its 12-month plan. Code and \"from\" prices are listed separately because they do not describe a standing monthly bill: Fridays shows $69 with a promo code, and Gala Health a \"from $69\" price set at checkout.",
   "url": "https://glp1providercompare.com/cheapest-semaglutide-providers/",
   "date": "2026-11-20"
  },
  {
   "id": "nexlife-cost",
   "question": "How much does NexLife cost?",
   "answer": "NexLife charges $129 a month for compounded tirzepatide on its monthly plan and $125, $119 or $115 a month on 3-, 6- or 12-month plans, and $109 for compounded semaglutide, or $105, $99 or $95, prices in effect since November 6, 2026 and re-read on nexlife.us on November 20, 2026. The price is the same at every dose and there is no membership fee. A 12-month tirzepatide plan comes to $1,380. NexLife's FAQ says longer plans are paid upfront at checkout, while its plan pages say plans continue monthly unless canceled.",
   "url": "https://glp1providercompare.com/providers/nexlife/",
   "date": "2026-11-20"
  },
  {
   "id": "all-in",
   "question": "What does an all-in GLP-1 price mean?",
   "answer": "On this site, an all-in GLP-1 price is the medication price plus every mandatory recurring fee, such as a membership or program fee, on a month-to-month plan, read on the program's own pricing page and dated, which is the November 20, 2026 basis for every table here. Intro-month, sale, code, starting-at and prepaid prices are labelled separately and never ranked as standing prices. IVIM Health's $117 tirzepatide plus its $75 monthly program fee is $192 all-in, not $117. Programs whose sites blocked our reader keep their last figure, shown with its own date, until we can read them again.",
   "url": "https://glp1providercompare.com/methodology/",
   "date": "2026-11-20"
  },
  {
   "id": "membership",
   "question": "Which GLP-1 programs charge a membership fee on top of the medication?",
   "answer": "As of November 20, 2026, two compounded programs in our index add a fee to the medication price, IVIM Health with a $75 monthly program fee and Mochi Health with a $79 monthly membership ($49 on a 12-month plan), and brand-only services such as LifeMD, Calibrate and WeightWatchers Clinic charge a monthly fee before medication. The other programs with a standing compounded price say they charge no separate membership. Always add any required fee before comparing, because a low medication price with a monthly fee can cost more than a higher flat price.",
   "url": "https://glp1providercompare.com/no-membership-glp1-providers/",
   "date": "2026-11-20"
  },
  {
   "id": "flat-rate",
   "question": "Which GLP-1 programs charge the same price at every dose?",
   "answer": "As of November 20, 2026, 9 programs in our index with a standing month-to-month price charge the same compounded tirzepatide price at every dose, according to their own pricing pages: NexLife, Eden, Yucca Health, Gimme Care, Trillium, Rift, OrderlyMeds, Enhance.MD and Remedy Meds. Flat pricing means moving from 2.5 mg to 15 mg does not raise the bill. Dose-tiered programs cost more as the dose climbs: Emerge Weight Loss charges $224 at 2.5 mg and $269 at 10 mg per 4 weeks, and Mochi Health prices medication by dose on top of its membership.",
   "url": "https://glp1providercompare.com/flat-rate-glp1-providers/",
   "date": "2026-11-20"
  },
  {
   "id": "year-cost",
   "question": "What does a year of compounded tirzepatide cost?",
   "answer": "As of November 20, 2026, twelve months of compounded tirzepatide at standing month-to-month all-in prices, before tax and with any required fee included, costs $1,548 to $5,187 across the 13 programs in our index with a first-party price, counting 13 payments where a program bills every four weeks, and NexLife costs $1,548 month-to-month or $1,380 on its 12-month plan. Prepaid plans cut the yearly total but tie up money; check what happens to unshipped months if you stop. Brand Zepbound through LillyDirect runs $299 to $449 a month by dose, or $3,588 to $5,388 for a year at a single dose.",
   "url": "https://glp1providercompare.com/cheapest-glp1-12-month-cost/",
   "date": "2026-11-20"
  },
  {
   "id": "brand-vs-compounded",
   "question": "How do brand Zepbound and Wegovy self-pay prices compare with compounded?",
   "answer": "As of November 20, 2026, brand Zepbound costs $299 to $449 a month self-pay through LillyDirect and Wegovy pens $349 through NovoCare, while compounded tirzepatide runs $129 to $399 and compounded semaglutide $89 to $299 a month all-in in our index. The brand products are FDA-approved; compounded versions are not. The Wegovy pill is $149 to $299 by dose, Foundayo starts at $149, and new Wegovy pen patients pay $199 for two fills through December 31, 2026. Lilly's dose ladder was last readable on October 15, 2026.",
   "url": "https://glp1providercompare.com/brand-name-glp1-online/",
   "date": "2026-11-20"
  },
  {
   "id": "legal-status",
   "question": "Is compounded tirzepatide FDA-approved, and is it still available in November 2026?",
   "answer": "No: as of November 20, 2026, compounded tirzepatide and semaglutide are not FDA-approved, but state-licensed 503A pharmacies still fill them for individual prescriptions, and FDA's April 30, 2026 proposal to keep both off the 503B bulks list had no final decision. FDA warned Empower Pharmacy on September 18 and the seller RonanRx on October 30, 2026, and four compounding pharmacies recalled GLP-1 products this fall. They are not generic and not the same as Zepbound or Wegovy. Ask which pharmacy fills your prescription and check its license before you pay.",
   "url": "https://glp1providercompare.com/compounded-glp1-providers/",
   "date": "2026-11-20"
  }
 ]
}
